Taxanes in the treatment of cancer are associated with a significant incidence of
hypersensitivity reactions, which may preclude their use in patients in need of first line …

Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …

Management of adverse reactions induced by chemotherapy drug... : Current Opinion in
Allergy and Clinical Immunology Management of adverse reactions induced by chemotherapy …

Introduction: Phenotype I hypersensitivity reactions are the most commonly reported drug
reactions; however, precision medicine has made it possible to characterize new …

Recent findings show that single, non-neuronal cells are also able to learn signalling
responses developing cellular memory. In cellular learning nodes of signalling networks …

Background: Rapid drug desensitization (RDD) allows first-line therapies in patients with
immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD) and …

In recent years, there has been a noticeable development in oncological treatment,
including chemotherapy and biological treatment. Despite their significant effectiveness …

Isatuximab is an IgG1 monoclonal antibody (mAb) against CD38. Its indicated in
combination with carfilzomib-dexamethasone for the treatment of adults with refractory …

Background Paclitaxel is a chemotherapeutic agent used in the treatment of multiple types of
malignant tumors which was discovered from the Taxus brevofilia tree. In some patients …

One of the main objectives when assessing patients who react to antineoplastics must be to
ensure that they receive the required treatments without delay. From January to July 2021, at …